Growing at an annualized rate of over 16.5%, the c..

Nouvel article créé

2 années depuis - Traduire

Growing at an annualized rate of over 16.5%, the cell therapy manufacturing market is estimated to reach close to USD 11 Billion by 2030, claims Roots Analysis | #rootsanalysis #pharma #health

Growing at an annualized rate of over 16.5%, the cell therapy manufacturing market is estimated to reach close to USD 11

The approval of KYMIRAH®, YESCARTA®, Alofisel® and Zyntelgo® has increased the interest of pharma stakeholders in cell therapies; further, owing to the technical challenges in this field, outsourcing manufacturing operations has become a necessity